![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif)
therapeutic progesterone A synthetic form of the endogenous hormone progesterone. Progesterone binds to the progesterone receptor, resulting in dissociation of heat shock proteins, receptor phosphorylation, and transcription activation through direct or indirect interaction with transcription factors. This agent exerts inhibitory effects on estrogens by decreasing the number of estrogen receptors and increasing its metabolism to inactive metabolites. Progesterone induces secretory changes in the endometrium, decreases uterine contractility during pregnancy, and maintains pregnancy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif)
Synonym: | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | progesterone | | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | US brand names: | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | Colprosterone Gesterol 100 Lipo-Lutin Lucorteum Sol Luteohormone Progestin Prolutin | | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | Foreign brand names: | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | Corlutina Corluvite Cyclogest Gestiron Gestone Lutocyclin Lutocylin Lutocylin M Lutogyl Lutromone Progestasert Progesterol Progestogel Progestol Progeston Prolidon Syngesterone Utrogestan | | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | PRG | | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure name: | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) | delta4-pregnene-3,20-dione | | ![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20090114235219im_/http://www.cancer.gov/images/spacer.gif) |